Placebo matching nerandomilast

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Interstitial Lung DiseasesSystemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases

Phase 3

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

RecruitingNCT06806592

Boehringer IngelheimInterstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases

Start: 2025-09-13End: 2027-07-30Target: 400Updated: 2026-09-16

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

Not yet recruitingNCT07540988

Boehringer IngelheimInterstitial Lung Diseases

Start: 2026-09-14End: 2028-12-12Target: 466Updated: 2026-09-03